Trial Library
Latest round
- Series A
Last raised
- Dec 2025
Total raised
- $15M
Investors
- 7
About Trial Library
Based in California, US, and co-founded in 2022 by Hala Borno (CEO), and Steve Buck, Trial Library, Inc. is an oncology clinical trials company with a mission to improve health equity by expanding access to cancer precision medicine. In December 2025, Trial Library, Inc. The company provides a healthcare research-based platform that enables diagnoses and treatment of cancer patients as well as engages them in clinical trials with patient navigation assistance together with tools to address social determinants of health (SDoH). Patients can be engaged wherever they are in the treatment process with the trained Ally Navigators offered by the firm.
Who invested in Trial Library
7 investors across 2 rounds
See all investors in Trial Library
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Trial Library
Who invested in Trial Library?
Trial Library has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Trial Library raised?
Trial Library has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Trial Library last raise money?
Trial Library's most recent round on record is a Series A, in Dec 2025.
What does Trial Library do?
Based in California, US, and co-founded in 2022 by Hala Borno (CEO), and Steve Buck, Trial Library, Inc.
Where is Trial Library headquartered?
Trial Library is headquartered in San Francisco, US.
Which VCs invest in companies like Trial Library?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at Trial Library's stage. Their profiles are linked below.
VCs backing healthcare startups at Series A
Raising like Trial Library? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.